ROCK & ASSOCIATES for PRECISION PHARMACY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK New | Staff Asst., US House Committee on Budget - 1985 to 2000 |
Budget/Appropriations BUD
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK New | Staff Asst., US House Committee on Budget - 1985 to 2000 |
Law Enforcement/Crime/Criminal Justice LAW
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK New | Staff Asst., US House Committee on Budget - 1985 to 2000 |
Health Issues HCR
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK New | Staff Asst., US House Committee on Budget - 1985 to 2000 |
Pharmacy PHA
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK New | Staff Asst., US House Committee on Budget - 1985 to 2000 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.